Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 51407-925

10 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 51407-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Methylphenidate Hydrochloride Extended Release Tab 1)

Structural Formula (Methylphenidate Hydrochloride Extended Release Tab 1)
Chemical structure of methylphenidate hydrochloride, showing the molecular arrangement of atoms including a phenyl ring, ester functional group, and the hydrochloride salt form.*
FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)
A line graph comparing the mean plasma methylphenidate concentration (ng/mL) over time (hours) for two dosing regimens: Methylphenidate HCl Extended-Release Tablets 18 mg once daily and Methylphenidate 5 mg three times daily. The graph shows concentration levels on the y-axis and time on the x-axis, illustrating the pharmacokinetic profiles of the two formulations over a 32-hour period.*
FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)
A bar chart comparing maximum symptoms on the Inattention/Overactivity Scale between methylphenidate hydrochloride extended-release tablets once daily and placebo across three studies. Each study shows two bars: a black bar for methylphenidate and a white bar for placebo, with placebo consistently higher, indicating more symptoms.*
FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)
A line graph comparing combined attention subscale scores over 12 hours after an initial dose between methylphenidate hydrochloride extended-release tablets and placebo. The y-axis measures attention from less attentive to more attentive, and the x-axis shows hours post initial dose. Data points include mean values with standard error bars, illustrating differences between drug and placebo groups over time.*
FDA Label Image

Tirgen Logo (Methylphenidate Hydrochloride Extended Release Tab 5)

FDA Label Image

Trigen Logo (Methylphenidate Hydrochloride Extended Release Tab 6)

FDA Label Image

51407-924-01 (pl) Rev. 0225 Art1.jpg51407-924-01 (pl) Rev. 0225 Art1.jpg (51407 924 01 (pl) Rev. 0225 Art1)

51407-924-01 (pl) Rev. 0225 Art1.jpg51407-924-01 (pl) Rev. 0225 Art1.jpg (51407 924 01 (pl) Rev. 0225 Art1)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP, 18 mg strength. The label includes dosage details, storage instructions (20°-25°C), and safety warnings to keep medication out of reach of children. Marketed by GSMS, Incorporated, the label indicates a container of 100 tablets for prescription use only and displays a barcode and NDC 51407-924-01.*
FDA Label Image

51407-925-01 (pl) Rev. 0225 Art1.jpg (51407 925 01 (pl) Rev. 0225 Art1)

51407-925-01 (pl) Rev. 0225 Art1.jpg (51407 925 01 (pl) Rev. 0225 Art1)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP, 27 mg strength. The label includes the NDC number 51407-925-01, storage instructions, and pharmacist dispensing information. It shows a package count of 100 tablets and is marked Rx Only. Marketed by GSMS, Incorporated, Camarillo, CA, USA. The label features a barcode and dosage guidance.*
FDA Label Image

51407-926-01 (pl) Rev. 0225 Art1.jpg (51407 926 01 (pl) Rev. 0225 Art1)

51407-926-01 (pl) Rev. 0225 Art1.jpg (51407 926 01 (pl) Rev. 0225 Art1)
Label for Methylphenidate Hydrochloride extended-release tablets, USP, 36 mg strength. The label indicates a package containing 100 tablets for oral use. It includes storage instructions to keep at 20°-25°C and protect from moisture. Marketed by GSMS, Incorporated, Camarillo, CA. The label features the NDC 51407-926-01 and a barcode.*
FDA Label Image

51407-927-01 (pl) Rev. 0225 Art1.jpg (51407 927 01 (pl) Rev. 0225 Art1)

51407-927-01 (pl) Rev. 0225 Art1.jpg (51407 927 01 (pl) Rev. 0225 Art1)
Methylphenidate Hydrochloride extended-release tablets, 54 mg, in a bottle label format. The label shows the NDC 51407-927-01 and contains 100 tablets. It is marketed by GSMS, Incorporated, Camarillo, CA. The label includes storage instructions, a pharmacist note to dispense the medication guide, and a barcode with GTIN 00351407927019.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.